Table 5.
Model | Cost Per Encounter |
Reimbursement Per Encounter |
Net Profit Per Encounter |
|||
---|---|---|---|---|---|---|
Bevacizumab | Aflibercept | Bevacizumab | Aflibercept | Bevacizumab | Aflibercept | |
With VA and DFE encounter | $85.55 | $1787.58 | $284.32 | $2124.78 | $198.77 | $337.20 |
OCT-only encounter | $68.85 | $1779.88 | $193.93 | $2034.39 | $125.08 | $263.51 |
DFE = dilated fundus examination; OCT = optical coherence tomography; VA = visual acuity.